Skip to main content

Table 3 Annual number of disease cases in canada under each vaccine program

From: Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada

Program IPD PNE AOM
  Bacteremia Meningitis In-patient Out-patient Mild Moderate/Severe
Direct and indirect effects
PCV13 10,427 368 101,325 257,356 762,343 118,999
PCV10 14,511 512 110,085 263,557 789,344 122,150
Direct effects only
PCV13 14,459 510 108,785 262,485 785,018 121,437
PCV10 14,511 512 110,085 263,557 789,344 122,150
  1. AOM acute otitis media; IPD invasive pneumococcal disease; PCV10 10-valent pneumococcal conjugate vaccine; PCV13 13-valent pneumococcal conjugate vaccine; PNE pneumonia.